Alzamend Neuro, Inc. - ALZN
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DRW Securities, LLC | History | Added to | 116,319 | 211 | 0.01% | 0.0% | 1 | +25,074 | 27.48% | Q4 2025 | Feb 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 27,506 | 50 | 0.0% | 0.0% | 2 | +6,928 | 33.67% | Q4 2025 | Feb 09, 2026 |
| UBS Group AG | History | Added to | 24,567 | 44 | 0.0% | 0.0% | 3 | +22,492 | 1083.95% | Q4 2025 | Jan 29, 2026 |
| VANGUARD GROUP INC | History | No change | 21,620 | 39 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q4 2025 | Jan 29, 2026 |
| MORGAN STANLEY | History | New | 18,000 | 32 | 0.0% | — | 5 | +18,000 | New | Q4 2025 | May 27, 2026 |
| Virtu Financial LLC | History | New | 12,582 | 23 | 0.0% | — | 6 | +12,582 | New | Q4 2025 | Feb 23, 2026 |
| XTX Topco Ltd | History | New | 12,470 | 22 | 0.0% | — | 7 | +12,470 | New | Q4 2025 | Feb 17, 2026 |
| Clearstead Advisors, LLC | History | No change | 10,000 | 18 | 0.0% | 0.0% | 8 | 0 | 0.0% | Q4 2025 | Feb 09, 2026 |
| Tower Research Capital LLC (TRC) | History | Added to | 2,081 | 3 | 0.0% | 0.0% | 9 | +475 | 29.58% | Q4 2025 | Feb 17, 2026 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 43 | 0 | — | — | — | +6 | 16.22% | Q4 2025 | Feb 17, 2026 |
| CITIGROUP INC | History | Closed out | 0 | 0 | — | — | — | -1 | -100.0% | Q4 2025 | Feb 13, 2026 |
| HARBOR INVESTMENT ADVISORY, LLC | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Jan 07, 2026 |
| SBI Securities Co., Ltd. | History | No change | 22 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 03, 2026 |
| BlackRock, Inc. | History | No change | 437 | 0 | — | 0.0% | — | 0 | 0.0% | Q4 2025 | Feb 12, 2026 |